Improvement of well-being under Cannabinoid extracts in palliative oncology patients.
- Conditions
- Oncologic patients undergoing palliative oncologic treatment.
- Registration Number
- DRKS00031009
- Lead Sponsor
- niversitätsklinikum Schleswig-Holstein,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 170
Palliative oncological therapy
- Eastern Cooperative Oncology Group (ECOG) status 1, 2, or 3 and no longer able to work
- Edmonton Symptom Assessment System (ESAS) total symptom distress score (TSDS) > 15
- Nutrition Risk Score > 3 (Kondrup et al., 2003)
- Pain numerical rating scale > 3
- Written informed consent after detailed explanation of the conduct and risks of the planned study (informed consent)
- For women of childbearing age (WOCBP)
o Negative pregnancy test
o Safe contraception (Pearl Index < 1%) of pregnancy (ovulation inhibitors, heterosexual abstinence, menopause, vasectomized partner, bilateral tubal occlusion, or combination of two less safe methods).
- Nausea/vomiting (exclusion criterion only).
- Inability to understand and complete the questionnaires
- Cannabis use in the last 2 years
- Alcohol dependence
- Pregnancy/breastfeeding
- Contraindications or intolerance of study medication (see Tab. 1), especially psychoses
- Simultaneous participation in other clinical studies (verification by self-report)
- Any other condition that, in the opinion of the responsible investigator, makes the subject unsuitable for participation in the study, e.g. (expected) poor communication skills or compliance
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptom change as change in ESAS-TSDS score (percent) at 12±2 days compared to baseline between THC:CBD intervention groups and placebo control group.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.